Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Piramal Life Sciences CEO Somesh Sharma On Managing Risk And India's Potential For Discovering New Drugs: An Interview With PharmAsia News (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Piramal Life Sciences CEO Somesh Sharma keeps a very low profile and does not speak much about his three decades of leading start-ups in the U.S., but his passion for research has fueled the determination of the Piramal Healthcare group to discover and develop a new molecular compound - which would be a first for India's pharma industry.

You may also be interested in...



India’s Piramal Ropes In Big Pharma Heavyhitters To Support Late-Stage R&D

MUMBAI - A progressively maturing pipeline of innovative compounds has led Piramal Healthcare Ltd. to begin adding leadership positions to its core research team. Piramal is believed to be drawing senior-level executives from established global companies in functions like drug discovery, development, international regulatory affairs and marketing strategies to ramp up expertise in late-stage processes

India’s Piramal Ropes In Big Pharma Heavyhitters To Support Late-Stage R&D

MUMBAI - A progressively maturing pipeline of innovative compounds has led Piramal Healthcare Ltd. to begin adding leadership positions to its core research team. Piramal is believed to be drawing senior-level executives from established global companies in functions like drug discovery, development, international regulatory affairs and marketing strategies to ramp up expertise in late-stage processes

Piramal Life Sciences CEO Somesh Sharma On Managing Risk And India's Potential For Discovering New Drugs: An Interview With PharmAsia News (Part 2 of 2)

Piramal Life Sciences CEO Somesh Sharma keeps a very low profile and does not speak much about his three decades of leading start-ups in the U.S., but his passion for research has fueled the determination of the Piramal Healthcare group to discover and develop a new molecular compound - which would be a first for India's pharma industry.

Related Content

UsernamePublicRestriction

Register

SC073301

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel